- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsing Chronic Myelogenous Leukemia in Canada
Total 244 results
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Philadelphia-Positive Myeloid LeukemiaBelgium, Spain, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Puerto Rico, Singapore, South Africa, Taiwan, United Kingdom, Australia, France, Philippines, Sweden, Thailand, Russian Federation, China, Poland, Finland, Isra... and more
-
PETHEMA FoundationCompleted
-
Novartis PharmaceuticalsCompletedLeukaemia, Lymphocytic, ChronicIndia, United Kingdom, Netherlands, Canada, Germany, Greece, Italy, Poland, Russian Federation, Spain, Taiwan, Thailand, United States, Brazil, Bulgaria, Mexico, Romania, Ukraine
-
CelgeneCompletedAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States, Canada
-
Novartis PharmaceuticalsTerminatedLeukaemia, Lymphocytic, ChronicSpain, United States, Belgium, India, United Kingdom, Netherlands, Czechia, Germany, Greece, Italy, Russian Federation, Sweden, Canada, Ireland, Poland, France, Brazil
-
Sunnybrook Health Sciences CentreNovartisCompleted
-
British Columbia Cancer AgencyUniversity of Victoria; BC Cancer FoundationCompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)Canada
-
University Health Network, TorontoCelgene CorporationCompleted
-
CancerCare ManitobaThe Leukemia and Lymphoma SocietyTerminatedChronic Lymphocytic LeukemiaCanada
-
Novartis PharmaceuticalsTerminatedLeukaemia, Lymphocytic, ChronicBelgium, Netherlands, United States, Argentina, Czechia, Denmark, France, Greece, Israel, Russian Federation, Sweden, Korea, Republic of, Australia, Brazil, Canada, Italy, Spain, Turkey, Hungary, Finland, Poland, Ukraine, Puerto Rico, Indi... and more
-
Sunnybrook Health Sciences CentreNovartisUnknownLeukemia, Lymphocytic, Chronic, B-CellCanada
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Celgene... and other collaboratorsCompletedIDH2 Mutation | Accelerated/Blast-phase Myeloproliferative Neoplasm | Chronic-phase MyelofibrosisUnited States, Canada
-
Jewish General HospitalNovartis PharmaceuticalsTerminatedChronic Lymphocytic LeukemiaCanada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.CompletedChronic Lymphocytic LeukemiaCanada
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Leukemia, Lymphoblastic, Acute, Philadelphia-positiveNetherlands, United States, Italy, Argentina, Austria, Brazil, Canada, Germany, Peru, United Kingdom, France, Korea, Republic of, Sweden, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzerland
-
University Health Network, TorontoTakara Bio Inc.RecruitingRelapsed or Refractory Chronic Lymphocytic Leukemia | Relapsed or Refractory Small Lymphocytic Lymphoma | Relapsed or Refractory CD19+ B-cell LymphomaCanada
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaCanada
-
Janssen Research & Development, LLCCompletedB-Cell Chronic Lymphocytic LeukemiaSpain, Russian Federation, Canada
-
Eleah StringerBC Cancer FoundationCompletedNeoplasms | Inflammation | Lymphoma, Small Lymphocytic | Diet Habit | Intermittent Fasting | Leukemia, Lymphocytic, ChronicCanada
-
Ottawa Hospital Research InstituteRecruitingNon-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaCanada
-
Canadian Cancer Trials GroupNovartisCompletedChronic Lymphocytic LeukemiaCanada
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent... and other conditionsCanada
-
Gemin XCompletedChronic Lymphocytic LeukemiaUnited States, Canada
-
Sunnybrook Health Sciences CentreAstraZenecaWithdrawnCOVID-19 | Chronic Lymphocytic LeukemiaCanada
-
Eisai Inc.CompletedLeukemia, Lymphocytic, ChronicCanada, Australia, United States, Argentina, Brazil
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaCanada
-
University Health Network, TorontoTerminatedLymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Multiple Myeloma | Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | MyelodysplasiaCanada
-
Treadwell Therapeutics, IncRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | AML | MDS | CMMLHong Kong, United States, Canada
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic SyndromesCanada, United States
-
Canadian Cancer Trials GroupActive, not recruiting
-
AbbVieCompleted
-
Mirati Therapeutics Inc.CompletedLymphocytic Leukemia, ChronicUnited States, Canada
-
Forma Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States, Spain, Korea, Republic of, Australia, Canada, Germany, France, United Kingdom, Italy
-
SecuraBioTerminatedLymphoma, Small Lymphocytic | Lymphocytic Leukemia, ChronicUnited States, Canada
-
Genzyme, a Sanofi CompanyCompletedB-Cell Chronic Lymphocytic LeukemiaSweden, United States, Croatia, Canada, Ukraine, Austria, Bulgaria, France, Germany, Greece, Italy, Poland, Portugal, Romania, Russian Federation
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinCanada, Spain, United States, Austria
-
Aegera TherapeuticsThe Leukemia and Lymphoma SocietyTerminatedLymphoma, B-Cell | Leukemia, Lymphocytic, Chronic, B-CellCanada, United States
-
Stemline Therapeutics, Inc.CompletedMyelofibrosis | Chronic Myelomonocytic LeukemiaUnited States, Canada
-
PfizerCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeSpain, Canada, Austria, Czechia, France, Hungary, Italy, Japan, Mexico, Poland, United Kingdom
-
CelgeneCompletedChronic Lymphocytic Leukemia | Leukemia, B-Cell, ChronicCanada, United States, Germany, Italy, Spain, Sweden, United Kingdom
-
AstraZenecaCompletedChronic Lymphocytic LeukemiaMalaysia, Saudi Arabia, India, Mexico, Brazil, Singapore, Egypt, Taiwan, Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Kuwait, Panama, Turkey, United Arab Emirates
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia (CLL)United States, France, Italy, Poland, Canada, Israel, Germany, Belgium
-
Lundbeck Canada Inc.CompletedChronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaCanada
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
Gilead SciencesTerminatedChronic Lymphocytic LeukemiaUnited States, France, Spain, Poland, United Kingdom, Australia, Belgium, Canada
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; NCIC Clinical Trials Group; SWOG Cancer Research...CompletedStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
CelgeneCompletedRelapsed or Refractory Chronic Lymphocytic LeukemiaUnited States, Canada, United Kingdom, France, Germany, Spain, Italy, Sweden
-
Sunnybrook Health Sciences CentreCelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myelomonocytic, Chronic | AngiogenesisCanada